Eurofins Expands Presence in Discovery Pharmacology With the Acquisition of Pan Labs US

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific, Inc. (Paris:ERF), (www.eurofinsus.com) the world leader in analytical support to the global pharmaceutical market, announces the signing of an agreement to acquire the Pan Labs pharmacology unit that was formerly operated by Ricerca Biosciences LLC and MDS Pharma. Pan Labs is a leading provider in early stage discovery services with a portfolio that provides molecular pharmacology, functional pharmacology, cellular services, and informatics analytics. The acquisition of this division from Ricerca Biosciences strengthens Eurofins’ growing presence in the US and Taiwan, while adding a unique business possessing the most advanced expertise in high quality Discovery CRO services. Pan Labs has over 150 highly qualified employees and USD 20m in annual revenues with most of the largest global pharmaceutical companies.